Skip to main content
Top
Published in: Breast Cancer 3/2008

01-07-2008 | Special Feature

Current state and future of diagnostic breast imaging

Author: Hiroko Tsunoda-Shimizu

Published in: Breast Cancer | Issue 3/2008

Login to get access

Excerpt

Circumstances concerning the diagnosis and treatment of breast cancer have changed considerably over the last few years. Progress in diagnostic techniques has been surprising, and various modalities have been put to effective use in actual clinical settings. In addition, treatment has gone from a time when only surgical management was performed to one in which multiple therapies like pre- and postoperative chemotherapy, hormone therapy, and therapy with molecular targeted agents are performed; techniques like sentinel node biopsy have also become firmly established. In line with such changes in treatment, what is demanded of diagnosis has also changed from simply determining whether or not a tumor is breast cancer to varied tasks such as diagnosis of cancer spread and determing or predicting the effects of neoadjuvant therapy. …
Metadata
Title
Current state and future of diagnostic breast imaging
Author
Hiroko Tsunoda-Shimizu
Publication date
01-07-2008
Publisher
Springer Japan
Published in
Breast Cancer / Issue 3/2008
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-008-0047-y

Other articles of this Issue 3/2008

Breast Cancer 3/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine